AmpliPhi Biosciences intends to develop the commercial potential of its products through licensing partners on a global basis. AmpliPhi will develop its lead products through initial clinical development and then seek global and/or regional partners.
In the meantime, AmpliPhi welcomes approaches from interested partners, as well as companies wishing to co-develop AmpliPhi’s technology in other ways.
Latest News
January 31st 2012
January 2012 Shareholder Letter
MoreJanuary 04th 2012
BioWorld Today features AmpliPhi CEO Phil Young
MoreNovember 21st 2011
AmpliPhi Biosciences Announces First Closing of $2.7m
MoreNovember 08th 2011
AmpliPhi Biosciences appoints Philip J. Young as President and CEO
MoreSeptember 06th 2011
AmpliPhi Biosciences to Present at Rodman & Renshaw Annual Global Investment Conference in New York
More